What happens at a psychiatric medication follow-up?

The appointment starts with a deceptively small question: “How’s the medication going?”

You have 11 thoughts. Sleep is better. Mornings are still rough. Your appetite has moved into a different apartment. You missed three doses during a work trip, but that feels like a confession. So you say, “Fine, probably.”

Fine is a respectable word and a terrible data set.

A useful psychiatric medication follow-up isn’t a refill conveyor belt. It’s a structured comparison between what you hoped would change, what actually changed, what the treatment costs you, and what should happen next.

The visit should begin before the video connects

Make a short note with four headings: better, unchanged, worse, and questions. Under each, add one or two examples. “Anxiety better” becomes “I attended two meetings without leaving early.” “Sleep worse” becomes “I’m awake until 2 a.m. on four nights a week.”

Bring an accurate list of prescriptions, over-the-counter medicines, vitamins, supplements, caffeine, nicotine, alcohol, cannabis, and other substances. Include what you actually take, not only what the label requested. Missed doses, changed timing, and self-adjusted amounts are clinical information, not evidence in a character trial.

If another clinician prescribed something, mention it. Medicines can interact, and a new symptom may come from the treatment, the condition being treated, another medical problem, a substance, or life happening with extremely poor timing.

Benefit means more than “Do you feel better?”

A prescriber may ask about the symptoms that led to treatment and about daily functioning. Are you getting out of bed? Finishing assignments? Driving safely? Returning messages? Having fewer panic attacks? Enjoying anything? The useful target depends on why the medicine was started.

Some practices use brief rating scales. This is called measurement-based care when symptom measures are collected repeatedly and used alongside conversation and clinical judgment. Reviews suggest it can help clinicians detect stalled progress and support treatment decisions, especially in depression care. A questionnaire isn’t the visit. It’s one instrument on the dashboard.

Memory is a gifted editor and a terrible archivist. A rough weekly note can show that panic fell from daily to twice a week even though Tuesday was awful. It can also show that a medication you thought was helping hasn’t changed the function you care about.

I’ll often ask, “What can you do now that you couldn’t do before?” The answer can reveal progress that a mood adjective misses. It can also expose a treatment that has improved a score without improving your life.

Side effects deserve names, timing, and consequences

Say what happened, when it began, whether it changed after a dose adjustment, and how much it matters. Nausea that lasted two mornings is different from nausea that makes you skip breakfast every day. Sleepiness at bedtime is different from nodding off while driving.

Don’t minimize sexual side effects, emotional blunting, weight or appetite changes, restlessness, tremor, sweating, constipation, dizziness, headaches, or cognitive problems because they feel awkward or “not serious enough.” A treatment you can’t tolerate won’t become sustainable through politeness.

Also don’t assume every new feeling is caused by the prescription. Timing helps. So do sleep, illness, menstrual changes, stress, other medicines, and substance use. The prescriber’s job is to sort possibilities with you, not defend the molecule.

Seek urgent help for severe reactions such as trouble breathing, swelling of the face or throat, fainting, a seizure, dangerous confusion, a high fever with severe stiffness or agitation, or thoughts you may act on. If suicidal thoughts are present or you can’t stay safe, call or text 988 or use emergency services. Don’t wait for the next routine appointment.

“I didn’t take it” is useful information

People miss medicines because of side effects, cost, travel, pharmacy delays, stigma, forgetfulness, ambivalence, or because taking a pill every morning can feel like receiving unwanted mail from your diagnosis. Each reason suggests a different solution.

NICE guidance recommends asking about adherence without blame and revisiting what a person believes about the medicine. That matters. If you’re unconvinced, worried about dependence, hoping to stop soon, or taking it only on hard days, say so. A plan built around fictional adherence is professionally decorated fiction.

Don’t abruptly stop or change a psychiatric medicine unless you’ve been told how to do so safely. Some medicines can cause withdrawal or rebound symptoms, and others carry condition-specific risks. If you already changed it, report exactly what happened. The safest next step starts from the real dose.

Monitoring should fit the medicine and the person

Not every follow-up needs the same checklist. Depending on the medicine, diagnosis, age, pregnancy possibility, medical history, and other risks, monitoring may include blood pressure, pulse, weight, movement symptoms, sleep, appetite, laboratory tests, an electrocardiogram, or medication blood levels.

The interval matters too. Early follow-up may be closer when a medicine is new, symptoms are severe, side effects are emerging, or safety needs watching. Stable long-term treatment may allow more space. The right schedule isn’t a universal number hidden in a scheduling app.

Ask what warning signs should trigger an earlier call and who to contact after hours. Know whether your practice handles refill requests through a portal, pharmacy, phone line, or carrier pigeon apparently trained by your insurance plan.

The next decision should belong to the conversation

A good follow-up may end with no change. It may lead to more time at the same dose, an adjustment, a switch, added therapy, attention to sleep or substance use, medical testing, or a gradual discontinuation plan. More medication isn’t automatically more care. Less medication isn’t automatically more enlightened.

Shared decision-making means the prescriber brings evidence, safety knowledge, and clinical judgment while you bring your experience, goals, tolerance for risk, and preferences. NICE and psychiatric guidelines emphasize that treatment decisions should involve the person taking the medicine. Your values aren’t a side note after the “real” medical work.

You’re allowed to say the proposed plan doesn’t fit. A prescriber can’t weigh a side effect you haven’t named, and you won’t protect the relationship by agreeing to something you aren’t likely to do. That’s not resistance. It’s information, and it shouldn’t have to leave the visit disguised as silence.

Before the visit ends, repeat the plan in plain English: what changes today, when to take it, what to monitor, what would prompt contact, and when you’ll meet again. If the plan has six moving parts, ask for it in writing.

Today’s experiment is a two-minute follow-up note. Write one concrete benefit, one cost, one adherence fact, and one question. That’s enough to turn “fine, probably” into a visit that can actually make a decision.

Sources: American Psychiatric Association, Practice Guidelines for the Psychiatric Evaluation of Adults (2016); NICE, Medicines Optimisation and Medicines Adherence; Gondek and colleagues, “The Impact of Measurement-Based Care in Psychiatry,” Journal of the American Psychiatric Nurses Association (2023); Psychiatric Services, “Implementation of Measurement-Based Care in Mental Health Services: A Systematic Literature Review” (2026).